-
Haizheng pharmaceutical and celsion sign a memorandum of understanding to continue to promote thermodox
Time of Update: 2020-04-03
Haizheng pharmaceutical announced in the evening of July 19 that on July 19, the company signed a memorandum of understanding with celsion company of the United States to continue to promote the clini
-
2015 global biopharmaceutical industry event!
Time of Update: 2020-04-03
China's pharmaceutical industry has undergone extensive and profound changes in 2015, which makes people feel shocked and at a loss For example, the consistency evaluation of generic drugs continues t
-
Further postponement of approval of three FDA preparations of Huahai pharmaceutical
Time of Update: 2020-04-03
Huahai pharmaceutical said the company's three FDA preparation numbers are still waiting for FDA approval It is worth mentioning that the company previously said in a conference call that the three pr
-
Ironwood pharmaceutical company submits the new drug application for iw2143 to FDA
Time of Update: 2020-04-03
Ironwood pharmaceutical company submits the application for new drug iw-2143 (ind) to the US Food and Drug Administration (FDA) for clinical research Clinical studies will further evaluate the pharmac
-
FDA approval of Roche MEK inhibitor cotellic
Time of Update: 2020-04-03
The FDA approved cotellic, Roche's MEK inhibitor, and vemurafenib, BRAF inhibitor, for the treatment of BRAF V600E or v600k variant advanced melanoma This is the second BRAF / MEK inhibitor combinatio
-
The treatment drug of type 2 diabetes mellitus, nichina, is listed in China
Time of Update: 2020-04-03
Algliptin benzoate is an oral dipeptidyl peptidase-4 inhibitor (dpp-4i) designed to delay the inactivation of glucagon like peptide-1 and GIP As a result, the number of insulin stimulated by the activ
-
Two new hepatitis B projects of guangshengtang failed to be approved
Time of Update: 2020-04-03
In April 2014, China Securities Regulatory Commission disclosed the prospectus of Fujian guangshengtang Pharmaceutical Co., Ltd (hereinafter referred to as "guangshengtang") This enterprise, which spe
-
Beijing green bamboo AC Hib triple vaccine, a subsidiary of Zhifei biology, is about to obtain production approval
Time of Update: 2020-04-03
The AC Hib triple vaccine independently developed by Beijing green bamboo bio Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Chongqing Zhifei Biological Products Co., Ltd., is expected to rece
-
Shanghai Kaibao's exclusive new product Tanreqing capsule
Time of Update: 2020-04-03
Shanghai Kaibao said on the interactive platform of investor relations that the company's exclusive new product, Tanreqing capsule, has been put into production and is preparing for listing Tanreqing
-
The patent for podophyllotoxin, a new anti-tumor drug of Jianfeng pharmaceutical, was approved
Time of Update: 2020-04-03
Zhejiang Jianfeng Pharmaceutical Co., Ltd., the holding subsidiary of Jianfeng group, has issued a patent certificate for the patent "a preparation method of deoxypodophyllotoxin" It is understood tha
-
Execitalopram oxalate tablets, a new Kangenbei 3.1 drug, has been approved for production
Time of Update: 2020-04-03
According to the latest information on the website of the State Food and drug administration, Kangenbei 3.1 new drug, escitalopram oxalate, has been approved for production The drug is a first-line an
-
Publicity of drug registration application to be included in the priority review procedure
Time of Update: 2020-04-03
According to the opinions of the State Administration on solving the backlog of drug registration applications and implementing the priority review and approval (sfjyhg [2016] No 19), our center organ
-
Tonghua Dongbao Ganjing insulin is expected to obtain clinical approval in the first half of the year
Time of Update: 2020-04-03
On May 9, an executive of Tonghua Dongbao disclosed in a conference call organized by a securities firm that the company's three generations of insulin, insulin glargine and insulin glargine injection
-
Hengrui shr7390 tablet and Baiji Shenzhou bgb-3111 capsule were approved for clinical use
Time of Update: 2020-04-03
The clinical application of class 1.1 new drugs of shr7390 tablets entered CFDA drug review center on December 31, 2014, and took a special review channel Shr7390 is a MEK kinase inhibitor developed f
-
Guangshengtang cooperates with yaomingkant in the treatment of hepatitis B and other new drugs
Time of Update: 2020-04-03
Guangshengtang (300436, Stock bar) issued a midday announcement The 13th board of directors of the second board of directors held on April 14, 2016 reviewed and passed the proposal on the consideratio
-
It is expected that the recombinant human follicle stimulating hormone for injection will be approved for market within this year
Time of Update: 2020-04-03
According to the information on August 4 on the website of the State Food and Drug Administration (CFDA), the recombinant human follicle stimulating hormone for injection of the heavy biological produ
-
Class 1.1 new drug of HongRi Pharmaceutical Co., Ltd. is about to obtain clinical approval
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on May 8, the declared clinical status of the 1.1 chemical drug of HongRi Pharmaceutical Co., Ltd., the raw material drug of p
-
The first phase of the cooperation project between Baiji Shenzhou and Merck xuelanuo for PARP inhibitors was successful
Time of Update: 2020-04-03
The latter paid $9 million in milestone payments to Baekje under the agreement This is Merck's second milestone payment since the cooperation with Baiji Shenzhou, and the first payment disclosed by PA
-
Yiteng pharmaceutical is authorized by syndex pharmaceutical to develop, produce and sell new anticancer drugs exclusively
Time of Update: 2020-04-03
Recently, Yiteng pharmaceutical, a leading professional pharmaceutical company in China, signed a license agreement with syndex pharmaceutical on the new anticancer drug entinostat Syndex pharmaceutic
-
GMP on-site inspection for long-acting growth hormone of Jinsai Pharmaceutical Co., Ltd. this month
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on May 21, the workshop of long-acting growth hormone (full name: polyethylene glycol recombinant human growth hormone injecti
